Edward Dow

Edward Dow has extensive experience in the field of hematology-oncology, with roles at various companies including New England Baptist Hospital, Lahey Clinic, and Norfolk Center for Cancer Care & Hematology. Edward has held leadership positions such as Vice President of Clinical Development at Oncternal Therapeutics and Chief Medical Officer at Value Genome, LLC. Dow has also served as a Consulting Medical Director for several biopharma companies in Immuno-Oncology & Hematology and as an Executive Medical Director at Sumitomo Dainippon Pharma Biopharma, Inc. Their responsibilities included leading medical affairs teams, strategic planning, and overseeing the development of novel therapies for cancer treatment.

Edward Dow attended Noble and Greenough School for their early education. Edward then went on to Harvard University, where they graduated Cum Laude with a Bachelor of Arts in History of Science. Later, they pursued their medical education at Tufts University School of Medicine, earning a Doctor of Medicine (MD) degree. Edward also obtained a certification in Hematology from the American Board of Internal Medicine.